• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个 11-lncRNA 风险评分模型预测肺鳞状细胞癌的预后。

An 11-lncRNA risk scoring model predicts prognosis of lung squamous cell carcinoma.

机构信息

Department of Respiration, Zhejiang Jinhua Guangfu Hospital, Jinhua, China.

出版信息

Eur Rev Med Pharmacol Sci. 2020 May;24(10):5456-5464. doi: 10.26355/eurrev_202005_21330.

DOI:10.26355/eurrev_202005_21330
PMID:32495880
Abstract

OBJECTIVE

The study aims to construct a multi-gene risk scoring model that can be used to predict the prognosis of patients with lung squamous cell carcinoma (LUSC).

PATIENTS AND METHODS

RNA-seq data from 494 LUSC tumor samples and 49 peripheral lung tissue samples were obtained from TCGA_LUSC database. Differential analysis was conducted using edgeR to screen differentially expressed lncRNAs (DElncRNAs) between LUSC and normal samples. Univariate Cox regression analysis was used to screen lncRNAs that were significantly correlated with LUSC prognosis. LASSO regression model was built to reduce complexity. The LUSC prognostic model based on lncRNAs was established by multivariate Cox regression analysis, which was evaluated by ROC curves and survival analysis. ROC and Kaplan-Meier survival curves of each lncRNA in the model were plotted and compared.

RESULTS

2085 DElncRNAs were identified. Combined with univariate Cox regression analysis, 342 prognosis-related genes were screened. After LASSO regression analysis, 11 lncRNAs tightly related to LUSC prognosis were identified and a risk scoring model was constructed. ROC curve analysis proved the good performance of the model. The Kaplan-Meier survival curve showed that the mortality in high-risk group was significantly higher. The survival analysis results of each lncRNA were also consistent with the prediction in Cox regression.

CONCLUSIONS

Our results suggested that the 11-lncRNA risk scoring model may provide a new insight for predicting prognosis of LUSC patients.

摘要

目的

本研究旨在构建一个多基因风险评分模型,用于预测肺鳞状细胞癌(LUSC)患者的预后。

方法

从 TCGA_LUSC 数据库中获取 494 例 LUSC 肿瘤样本和 49 例外周肺组织样本的 RNA-seq 数据。使用 edgeR 进行差异分析,筛选 LUSC 与正常样本之间差异表达的长非编码 RNA(DElncRNAs)。采用单因素 Cox 回归分析筛选与 LUSC 预后显著相关的 lncRNAs。构建 LASSO 回归模型以降低复杂性。通过多因素 Cox 回归分析建立基于 lncRNAs 的 LUSC 预后模型,通过 ROC 曲线和生存分析进行评估。绘制并比较模型中每个 lncRNA 的 ROC 和 Kaplan-Meier 生存曲线。

结果

鉴定出 2085 个 DElncRNAs。结合单因素 Cox 回归分析,筛选出 342 个与预后相关的基因。经过 LASSO 回归分析,确定了 11 个与 LUSC 预后密切相关的 lncRNAs,并构建了风险评分模型。ROC 曲线分析证明了该模型的良好性能。Kaplan-Meier 生存曲线显示,高危组的死亡率明显更高。每个 lncRNA 的生存分析结果也与 Cox 回归的预测一致。

结论

我们的结果表明,该 11-lncRNA 风险评分模型可能为预测 LUSC 患者的预后提供新的思路。

相似文献

1
An 11-lncRNA risk scoring model predicts prognosis of lung squamous cell carcinoma.一个 11-lncRNA 风险评分模型预测肺鳞状细胞癌的预后。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5456-5464. doi: 10.26355/eurrev_202005_21330.
2
Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.采用长链非编码 RNA 介导 ceRNA 网络的综合分析鉴定肺鳞状细胞癌中的 lncRNA 生物标志物。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3246-3258. doi: 10.1080/21691401.2019.1647225.
3
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.肺鳞状细胞癌中预后相关 lncRNAs、miRNAs 和 mRNAs 形成竞争内源性 RNA 网络的全基因组分析。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1711-1723. doi: 10.1007/s00432-020-03224-8. Epub 2020 Apr 30.
4
Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA.基于免疫原性细胞死亡相关长非编码 RNA 的肺鳞状细胞癌 PET/CT 预后预测模型的建立。
BMC Pulm Med. 2023 Dec 15;23(1):511. doi: 10.1186/s12890-023-02792-y.
5
M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.M7G 相关长非编码 RNA 预测肺鳞癌的预后并调节免疫微环境。
BMC Cancer. 2022 Nov 4;22(1):1132. doi: 10.1186/s12885-022-10232-z.
6
A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.一个用于预测肺鳞癌患者预后的 9 个长非编码 RNA 标志物。
Cancer Biomark. 2019;26(3):239-247. doi: 10.3233/CBM-182275.
7
Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.长非编码 RNA RP5-821D11.7、APCDD1L-AS1 和 RP11-277P12.9 与肺鳞状细胞癌的预后相关。
Mol Med Rep. 2018 May;17(5):7238-7248. doi: 10.3892/mmr.2018.8770. Epub 2018 Mar 16.
8
Development of a disulfidptosis-related lncRNA prognostic signature for enhanced prognostic assessment and therapeutic strategies in lung squamous cell carcinoma.用于增强肺鳞状细胞癌预后评估和治疗策略的二硫化物依赖性细胞坏死相关lncRNA预后特征的开发
Sci Rep. 2024 Aug 1;14(1):17804. doi: 10.1038/s41598-024-68423-6.
9
A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中失调的长非编码 RNA/ microRNA/ mRNAs 的系统分析。
Am J Med Sci. 2020 Dec;360(6):701-710. doi: 10.1016/j.amjms.2020.08.025. Epub 2020 Aug 22.
10
A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.用于肺鳞癌的预后 4 个长链非编码 RNA 表达特征。
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1207-1214. doi: 10.1080/21691401.2017.1366334. Epub 2017 Aug 24.

引用本文的文献

1
Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.用于预测肺鳞状细胞癌预后和免疫格局的N6-甲基腺苷(m6A)相关长链非编码RNA特征的鉴定
Front Oncol. 2021 Nov 18;11:763027. doi: 10.3389/fonc.2021.763027. eCollection 2021.
2
Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma.鉴定和验证肺腺癌中一种新的氧化还原相关长非编码 RNA 预后标志物。
Bioengineered. 2021 Dec;12(1):4331-4348. doi: 10.1080/21655979.2021.1951522.